Francesco Leo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francesco Leo has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Lorenzo Spaggiari
Department of Oncology and Hemato-oncology, University of Milan, 20122 Milan, Italy
6 shared publications - Jérôme Mouroux
Department of Thoracic Surgery, Université Côte d’Azur, CHU de Nice, University Hospital Federation OncoAge, 06001 Nice Cedex 1, France
5 shared publications - Domenico Galetta
Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy
4 shared publications Alessandro Borri
European Institute of Oncology, Milan, Italy
3 shared publicationsDavide Radice
3 shared publicationsGiuseppe Pelosi
3 shared publications
Latest Publications
- 13 April 2012
- Vol. 98 (2012Januar) , 90-3
Pulmonary resections: cytostructural effects of different-wavelength lasers versus electrocautery
There are few papers on the cytostructural effects of surgical instruments used during pulmonary resections. The aim of the present study was to evaluate the parenchymal damage caused by different surgical instruments: a new generation electrosurgical scalpel and two different-wavelength lasers. Six surgical procedures of pulmonary resection for nodules were performed using a new generation electrosurgical scalpel, a 1318 nm neodymium (Nd:YAG) laser or a 2010 nm thulium laser (two procedures for each instrument). Specimens were analyzed using optical microscopy and scansion electronic microscopy. Severe cytostructural damage was found to be present in an average of 1.25 mm in depth from the cutting surface in the patients treated using electrosurgical cautery. The depth of this zone dropped to less than 1 mm in patients treated by laser, being as small as 0.2 mm using the laser with a 2010 nm-wavelength and 0.6 mm with the 1318 nm-wavelength laser. These preliminary findings support the use of laser to perform conservative pulmonary resections (i.e., metastasectomies), since it is more likely to avoid damage to surrounding structures. Controlled randomized trials are needed to support the clinical usefulness and feasibility of new types of lasers for pulmonary resections.
- 13 April 2012
- Vol. 98 (2012Januar) , 90-3
Pulmonary resections: cytostructural effects of different-wavelength lasers versus electrocautery
There are few papers on the cytostructural effects of surgical instruments used during pulmonary resections. The aim of the present study was to evaluate the parenchymal damage caused by different surgical instruments: a new generation electrosurgical scalpel and two different-wavelength lasers. Six surgical procedures of pulmonary resection for nodules were performed using a new generation electrosurgical scalpel, a 1318 nm neodymium (Nd:YAG) laser or a 2010 nm thulium laser (two procedures for each instrument). Specimens were analyzed using optical microscopy and scansion electronic microscopy. Severe cytostructural damage was found to be present in an average of 1.25 mm in depth from the cutting surface in the patients treated using electrosurgical cautery. The depth of this zone dropped to less than 1 mm in patients treated by laser, being as small as 0.2 mm using the laser with a 2010 nm-wavelength and 0.6 mm with the 1318 nm-wavelength laser. These preliminary findings support the use of laser to perform conservative pulmonary resections (i.e., metastasectomies), since it is more likely to avoid damage to surrounding structures. Controlled randomized trials are needed to support the clinical usefulness and feasibility of new types of lasers for pulmonary resections.
- 14 December 2011
- Vol. 97 (2011Septem) , 34e-5e
Unusual giant cell tumor of a floating rib: a case report
Giant cell tumor is an unusual neoplasm of the ribs. Herein is presented the case of a patient with an abdominal wall mass, which turned out to be a giant cell tumor of the 11th rib. This is a very uncommon site for a giant cell tumor, which also had a peculiar shape. No other similar case has been reported in the medical literature.
- 14 December 2011
- Vol. 97 (2011Septem) , 34e-5e
Unusual giant cell tumor of a floating rib: a case report
Giant cell tumor is an unusual neoplasm of the ribs. Herein is presented the case of a patient with an abdominal wall mass, which turned out to be a giant cell tumor of the 11th rib. This is a very uncommon site for a giant cell tumor, which also had a peculiar shape. No other similar case has been reported in the medical literature.
- 1 March 2010
- Published by Elsevier in Lung Cancer
- Vol. 67 (3) , 306-310
Structural lung damage after chemotherapy
- 1 March 2010
- Published by Elsevier in Lung Cancer
- Vol. 67 (3) , 306-310
Structural lung damage after chemotherapy
- 1 June 2009
- Vol. 15 (6) , 361-7
Does a personalized approach improve patient satisfaction in thoracic oncology?
To evaluate patients' quality of life (QOL) at admission to permit definition and implementation of a personalized plan of multidimensional care. In 2007, patients hospitalized for more than 24 hours at the Thoracic Surgery Department of a tertiary referral cancer center received QOL assessment at admission by European Organisation for Research and Treatment of Cancer (EORTC) questionnaires QLQ-C30 and LC13. Patients were asked to anonymously express their satisfaction with care at discharge by using the EORTC IN-PATSAT32 questionnaire. During the second part of the study (July-December 2007), specific interventions were proposed in critical areas identified by the questionnaires. During 2007, 898 patients completed QOL assessment at admission and 805 patients anonymously expressed their satisfaction with care at discharge. Overall patient satisfaction significantly improved in the second part of the study (85.4 +/- 16.7 vs 91.9 +/- 13.1; P = .009). The most significant improvement was recorded in nurses' information provision (67.7 +/- 24.1 vs 80.2 +/- 20.2; P = .0014) and availability (70.4 +/- 22.8 vs 84.3 +/- 19.2; P <.001). Surprisingly, the third-ranking improvement was recorded for the hospital access scale, which was the item with the lowest score in both periods and for which no specific modification occurred during the study period. Use of a simple and reliable evaluation of QOL at admission contributed to improved quality of administered care. This approach permits focused management of ongoing problems, close cooperation between caregivers, and a more flexible response to patient needs.
- 1 June 2009
- Vol. 15 (6) , 361-7
Does a personalized approach improve patient satisfaction in thoracic oncology?
To evaluate patients' quality of life (QOL) at admission to permit definition and implementation of a personalized plan of multidimensional care. In 2007, patients hospitalized for more than 24 hours at the Thoracic Surgery Department of a tertiary referral cancer center received QOL assessment at admission by European Organisation for Research and Treatment of Cancer (EORTC) questionnaires QLQ-C30 and LC13. Patients were asked to anonymously express their satisfaction with care at discharge by using the EORTC IN-PATSAT32 questionnaire. During the second part of the study (July-December 2007), specific interventions were proposed in critical areas identified by the questionnaires. During 2007, 898 patients completed QOL assessment at admission and 805 patients anonymously expressed their satisfaction with care at discharge. Overall patient satisfaction significantly improved in the second part of the study (85.4 +/- 16.7 vs 91.9 +/- 13.1; P = .009). The most significant improvement was recorded in nurses' information provision (67.7 +/- 24.1 vs 80.2 +/- 20.2; P = .0014) and availability (70.4 +/- 22.8 vs 84.3 +/- 19.2; P <.001). Surprisingly, the third-ranking improvement was recorded for the hospital access scale, which was the item with the lowest score in both periods and for which no specific modification occurred during the study period. Use of a simple and reliable evaluation of QOL at admission contributed to improved quality of administered care. This approach permits focused management of ongoing problems, close cooperation between caregivers, and a more flexible response to patient needs.
- Open Access
- 1 March 2009
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 35 (3) , 537
Segmentectomy for carcinoid arising from an accessory cardiac bronchus
A right lower lobe nodule associated with 2 mm nodule of the middle lobe was discovered in a 74-year-old female. The major lesion was in an accessory cardiac bronchus (Fig. 1 ) which was anatomically removed for diagnostic purpose (Fig. 2 ). Both lesions were typical carcinoids. This abnormality has never been reported before.
- 1 March 2009
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 35 (3) , 537
Open AccessSegmentectomy for carcinoid arising from an accessory cardiac bronchus
A right lower lobe nodule associated with 2 mm nodule of the middle lobe was discovered in a 74-year-old female. The major lesion was in an accessory cardiac bronchus (Fig. 1 ) which was anatomically removed for diagnostic purpose (Fig. 2 ). Both lesions were typical carcinoids. This abnormality has never been reported before.
- 31 October 2008
- Published by Elsevier in The American Journal of Surgery
- Vol. 196 (4) , e35-e37
The pleural and human fibrin glue sandwich: a quick and effective post-pneumonectomy bronchial stump coverage technique
- 31 October 2008
- Published by Elsevier in The American Journal of Surgery
- Vol. 196 (4) , e35-e37
The pleural and human fibrin glue sandwich: a quick and effective post-pneumonectomy bronchial stump coverage technique
- 1 March 2008
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 33 (3) , 424-429
Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?☆
One of the characteristics of chronic obstructive pulmonary disease (COPD) is the tendency to develop acute exacerbation, defined by the presence of different clinical findings as worsening dyspnea, increase in sputum purulence and volume. This study was designed to verify if definition of acute COPD exacerbation is applicable to patients who underwent pulmonary surgery, and if it has any impact on postoperative morbidity and mortality. This study was designed to prospectively enrol 1000 patients undergoing pulmonary resection for lung cancer from five different centres. Postoperative exacerbation of COPD was defined by the concomitant presence of three of the following five signs: deteriorating dyspnea, purulent sputum, bronchial secretion volume >10 ml/24 h, fever without apparent cause, and wheezing. The presence of concomitant pulmonary complications excluded the diagnosis of exacerbation, as they may present one or more of these signs. In the absence of respiratory complications, postoperative stay in exacerbated patients was significantly longer as compared to patients without exacerbation (6.3+/-1.3 vs 8.3+/-1.1, p=0.001). A postoperative exacerbation of COPD was recorded in 276 patients and 152 of them (55%) subsequently developed respiratory complications. Multivariate analysis established that risk factors for postoperative exacerbation are sex (female OR 0.54, CI 0.2-0.8), COPD class (OR 1.5, CI 1.1-8.1), and the postoperative prolonged use of antibiotics (OR 0.6, CI 0.2-0.9). Postoperative exacerbation of COPD is an existing, frequent clinical entity after lung resection and, when present, it increases the risk of pulmonary complications. The existing guidelines for the treatment of acute exacerbation should be adapted for the management of patients after lung resection in order to test the hypothesis that they could reduce respiratory morbidity.
- 1 March 2008
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 33 (3) , 424-429
Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?☆
One of the characteristics of chronic obstructive pulmonary disease (COPD) is the tendency to develop acute exacerbation, defined by the presence of different clinical findings as worsening dyspnea, increase in sputum purulence and volume. This study was designed to verify if definition of acute COPD exacerbation is applicable to patients who underwent pulmonary surgery, and if it has any impact on postoperative morbidity and mortality. This study was designed to prospectively enrol 1000 patients undergoing pulmonary resection for lung cancer from five different centres. Postoperative exacerbation of COPD was defined by the concomitant presence of three of the following five signs: deteriorating dyspnea, purulent sputum, bronchial secretion volume >10 ml/24 h, fever without apparent cause, and wheezing. The presence of concomitant pulmonary complications excluded the diagnosis of exacerbation, as they may present one or more of these signs. In the absence of respiratory complications, postoperative stay in exacerbated patients was significantly longer as compared to patients without exacerbation (6.3+/-1.3 vs 8.3+/-1.1, p=0.001). A postoperative exacerbation of COPD was recorded in 276 patients and 152 of them (55%) subsequently developed respiratory complications. Multivariate analysis established that risk factors for postoperative exacerbation are sex (female OR 0.54, CI 0.2-0.8), COPD class (OR 1.5, CI 1.1-8.1), and the postoperative prolonged use of antibiotics (OR 0.6, CI 0.2-0.9). Postoperative exacerbation of COPD is an existing, frequent clinical entity after lung resection and, when present, it increases the risk of pulmonary complications. The existing guidelines for the treatment of acute exacerbation should be adapted for the management of patients after lung resection in order to test the hypothesis that they could reduce respiratory morbidity.
- 31 January 2008
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 135 (1) , 210-211
What happens after pneumonectomy? A prospective study using the transpulmonary thermodilution method
- 31 January 2008
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 135 (1) , 210-211
What happens after pneumonectomy? A prospective study using the transpulmonary thermodilution method
- 1 May 2007
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 31 (5) , 779-782
The risk of pneumonectomy over the age of 70. A case–control study☆
A higher mortality has been reported after pneumonectomy over the age of 70. The aim of the study was to quantify the additional risk due to age after standard pneumonectomy for lung cancer by a case-control study. Our clinical database was reviewed to search for patients aged 70 years or more who underwent standard pneumonectomy for lung cancer between 1998 and 2005. A control group of patients younger than 70 (one case/two controls) was matched for sex, cardiovascular disease, American Association of Anaesthetists score, respiratory function, side of pneumonectomy, induction chemotherapy and stage. Overall mortality and morbidity were compared. Long-term survival data were also analysed. During the considered period, 35 patients aged 70 years or more underwent pneumonectomy (30 males, median age 73 years, 15 right-sided procedures). The control group was composed of 70 patients. The two groups were homogeneous in the variables used for matching. Overall mortality and morbidity were 11.4 and 54.2% in the elderly group as compared to 4.3 and 41.6% in controls (p-value not significant). Elderly patients experienced a higher rate of respiratory complications (25.7%) as compared to controls (8.3%, p=0.01). At univariate analysis, the only risk factor for death was the occurrence of respiratory complications (OR 6.5, CI 1.8-18.2). At multivariate analysis, age >or=70 years (OR 5.36, CI 1.48-19.3) and preoperative chemotherapy (OR 7.65, CI 2.04-28.6) were confirmed as predictors of respiratory complications. Five-year survival was 17.5% in the elderly group and 53.6% in the control group (p=0.003). Elderly patients with a better respiratory function (FEV1>70%) had a 5-year survival of 45.4%. In the elderly patients, the risk of respiratory complications after pneumonectomy is increased as compared to younger patients with equivalent respiratory function. Age and preoperative chemotherapy are independent risk factors for respiratory complications. A lower mortality and a better long-term survival are obtained in elderly patients with a better respiratory function (FEV1>or=70%).
- 1 May 2007
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 31 (5) , 779-782
The risk of pneumonectomy over the age of 70. A case–control study☆
A higher mortality has been reported after pneumonectomy over the age of 70. The aim of the study was to quantify the additional risk due to age after standard pneumonectomy for lung cancer by a case-control study. Our clinical database was reviewed to search for patients aged 70 years or more who underwent standard pneumonectomy for lung cancer between 1998 and 2005. A control group of patients younger than 70 (one case/two controls) was matched for sex, cardiovascular disease, American Association of Anaesthetists score, respiratory function, side of pneumonectomy, induction chemotherapy and stage. Overall mortality and morbidity were compared. Long-term survival data were also analysed. During the considered period, 35 patients aged 70 years or more underwent pneumonectomy (30 males, median age 73 years, 15 right-sided procedures). The control group was composed of 70 patients. The two groups were homogeneous in the variables used for matching. Overall mortality and morbidity were 11.4 and 54.2% in the elderly group as compared to 4.3 and 41.6% in controls (p-value not significant). Elderly patients experienced a higher rate of respiratory complications (25.7%) as compared to controls (8.3%, p=0.01). At univariate analysis, the only risk factor for death was the occurrence of respiratory complications (OR 6.5, CI 1.8-18.2). At multivariate analysis, age >or=70 years (OR 5.36, CI 1.48-19.3) and preoperative chemotherapy (OR 7.65, CI 2.04-28.6) were confirmed as predictors of respiratory complications. Five-year survival was 17.5% in the elderly group and 53.6% in the control group (p=0.003). Elderly patients with a better respiratory function (FEV1>70%) had a 5-year survival of 45.4%. In the elderly patients, the risk of respiratory complications after pneumonectomy is increased as compared to younger patients with equivalent respiratory function. Age and preoperative chemotherapy are independent risk factors for respiratory complications. A lower mortality and a better long-term survival are obtained in elderly patients with a better respiratory function (FEV1>or=70%).
- 5 April 2007
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 55 (3) , 203-204
Finding the Limit between Station 2 and Station 4 during Right-Sided Thoracotomy
Mediastinal lymph node dissection is a key part of resection for lung cancer to obtain a radical resection and accurate staging. On the right side, the upper limit of the paratracheal region is represented by lymph node station 2, which is separated from station 4 by a line drawn tangentially to the upper margin of the aortic arch [[ 1 ]]. This line is not visible during mediastinal dissection. Therefore, during right thoracotomy, the definition of station 2 is arbitrary. As the involvement of the nodal station 2 has been considered to be a marker for incomplete resection in many lung cancer trials [[ 2 ]], the precise definition of the lower limit of this station is important. Recently, we developed an intraoperative technique to assess this limit properly during mediastinoscopy [[ 3 ]]. We modified this simple technique for use during mediastinal dissection through a right thoracotomy.
- 5 April 2007
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 55 (3) , 203-204
Finding the Limit between Station 2 and Station 4 during Right-Sided Thoracotomy
Mediastinal lymph node dissection is a key part of resection for lung cancer to obtain a radical resection and accurate staging. On the right side, the upper limit of the paratracheal region is represented by lymph node station 2, which is separated from station 4 by a line drawn tangentially to the upper margin of the aortic arch [[ 1 ]]. This line is not visible during mediastinal dissection. Therefore, during right thoracotomy, the definition of station 2 is arbitrary. As the involvement of the nodal station 2 has been considered to be a marker for incomplete resection in many lung cancer trials [[ 2 ]], the precise definition of the lower limit of this station is important. Recently, we developed an intraoperative technique to assess this limit properly during mediastinoscopy [[ 3 ]]. We modified this simple technique for use during mediastinal dissection through a right thoracotomy.